Objective. Effective postoperative pain control reduces postoperative morbidity. In this study, we investigated the effects of intrathecal morphine, ketamine, and their combination with bupivacaine for postoperative analgesia in major abdominal cancer surgery.
Introduction
Effective postoperative pain control is an essential component of the care of surgical patients. Inadequate pain control, apart from being inhumane, may result in increased morbidity or mortality [1, 2] .
The advantages of effective postoperative pain management include patient comfort and therefore satisfaction, earlier mobilization, fewer pulmonary and cardiac complications, a reduced risk of deep vein thrombosis, faster recovery with less likelihood of the development of neuropathic pain, and reduced cost of care [3] .
Despite extensive discourse, there is still controversy in the literature as to the safety and analgesic efficacy of ketamine through the intrathecal route [4] [5] [6] [7] [8] [9] . Preservative-free racemic ketamine was shown to be devoid of neurotoxic effects after both single and repeated administration in animals [4] [5] [6] .
Ketamine, a phencyclidine derivative, has recently been found to be effective by epidural and intrathecal routes. It possesses some definite advantages over the conventional local anesthetic agents as it stimulates the cardiovascular system [10, 11] and respiratory system [12] .The onset of anesthesia (sensory block) and motor paralysis is found to be earlier than the conventional local anesthetics [11] . The intensity of the sensory block is 100% as it is described to be due to the potent analgesic effect of ketamine [13] .
Intrathecal opioid administration is an attractive analgesic technique as the opioid is injected directly into the cerebrospinal fluid, close to the structures of the central nervous system where the opioid acts. The procedure is simple, quick, and with a relatively low risk of technical complications or failure [14] .
However, it is known that intrathecal morphine, alone or as an adjuvant to a local anesthetic, increases the risk of respiratory depression. Respiratory depression is a major risk [15] .
The objective of this study was to investigate the effects of intrathecal morphine, ketamine, and their combination when added to bupivacaine for postoperative analgesia in major abdominal cancer surgery.
Methods
This randomized, double-blind study was approved by the ethics committee of South Egypt Cancer Institute, Assiut University, Assiut, Egypt (registered at www. ClinicalTrials.gov with identifier No. NCT02726828). After obtaining written informed consent, 90 American Society of Anesthesia (ASA) I-III patients age 30 to 50 years scheduled for major abdominal cancer surgery were included in the study. Patients with a known allergy to the study drugs, significant cardiac, respiratory, renal or hepatic disease, coagulation disorder, infection at or near the site of intrathecal injection, drug or alcohol abuse, body mass index (BMI) greater than 30, or psychiatric illnesses with the potential to interfere with perception and assessment of pain were excluded from the study.
Preoperatively, patients were taught how to evaluate their own pain intensity using the visual analogue scale (VAS), scored from 0 to 10 (where 0 ¼ no pain and 10 ¼ the worst pain imaginable).
Oral diazepam (5 mg) was given the night before surgery. Upon arrival at the operative theater, a 16-gauge catheter was introduced intravenously at the dorsum of the hand; lactated Ringer's solution 10 mg/kg was infused intravenously over 10 minutes before initiation of spinal anesthesia. Basic monitoring probes (electrocardiography, noninvasive blood pressure, O 2 saturation, and temperature) were applied. Patients were placed in the sitting position, and a 25-gauge Quincke needle was placed in the L 2-3 or L 3-4 interspaces.
Patients were randomly divided, by selecting sealed envelopes, into one of three groups (30 patients each):
• The morphine group (group M) patients received 10 mg of hyperbaric bupivacaine 0.5% in 2 mL volume and 0.3 mg morphine in 1 mL volume intrathecally.
• The ketamine group (group K) patients received 10 mg of hyperbaric bupivacaine 0.5% in 2 mL volume and 0.1 mg/kg ketamine in 1mL volume intrathecally.
• The morphine þ ketamine group (group M þ K) patients received 10 mg of hyperbaric bupivacaine 0.5% in 2 mL volume and 0.3 mg morphine plus 0.1 mg/kg of ketamine in 1 mL volume intrathecally.
Immediately after successful spinal anesthesia, the patients were placed in the supine position, general anesthesia was induced with fentanyl 1.5 to 2 mg/kg, propofol 2 to 3 mg/kg, and lidocaine 1.5 mg/kg. Endotracheal intubation was facilitated by cis-atracurium 0.15 mg/kg. Heart rate, systolic, and diastolic blood pressure were recorded at five, 10, 20, 30, 60, 120, 180 minutes. Anesthesia and muscle relaxation were maintained by isoflurane 1 to 1.5 MAC in 50% oxygen/ air mixture, and cis-atracurium 0.03 mg/kg bolus was given every 30 minutes.
At the end of surgery, muscle relaxation was reversed by neostigmine 50 mg/kg and atropine 10 mg/kg. Patients were extubated and transferred to a postanesthesia care unit (PACU) and monitored for vital signs (heart rate, noninvasive blood pressure, respiratory rate, and O 2 saturation) immediately postoperation and at two, four, six, 12, 18, and 24 hours postoperation.
Total analgesic consumption in the first 24 hours postoperation and the time of first request of analgesia were recorded. VAS scores were assessed at the same time intervals. Rescue analgesia was represented by patientcontrolled analgesia (PCA) with intravenous morphine, with an initial bolus of 0.1 mg/kg once pain was expressed by the patient or if VAS is 3 or more (VAS 3), followed by 1 mg boluses with a lockout period of five minutes. The patient's level of sedation was assessed at the same time points with scores from 0 to 4, where 0 ¼ awake, 1 ¼ easily aroused, 2 ¼ awakens after tactile stimulation, 3 ¼ awakens after verbal stimulation, and 4 ¼ not arousable.
The attendant anesthesiologist was blinded to patient assignment to a specific group. Postoperative adverse Abd El-Rahman et al.
effects such as nausea, vomiting, hypotension, bradycardia, and itching were recorded and treated.
Hypotension is defined as a 15% decrease in systolic blood pressure from baseline. Bradycardia is defined as a heart rate slower than 50 beats per minute or a decrease in heart rate of 20% or more from baseline, whichever is lowest. Hypoxia is defined as an oxygen saturation of less than 90%. Hypotension was treated with intravenous bolus of ephidrine 0.1 mg/kg and normal saline 5 mL/kg; the same doses were repeated as required. Bradycardia was treated with intravenous atropine 0.01 mg/kg.
Statistical Analysis

Power of the Study
The primary end point was the total dose of intravenous PCA morphine consumption in the first 24 hours postoperation. Secondary end points were the safety profile of the study drugs in terms of predefined adverse effects, nausea, vomiting, and level of sedation during the study period. To detect a difference of one SD [16] between the mean of the total amount of postoperative morphine consumption between the study groups in the 24 hours, we estimated that 28 patients in each group would be required to have a power of 90% and an alpha error not exceeding 0.05. We included 30 patients in each group to compensate for possible patient dropouts.
Data Analysis
Analysis was performed using the Statistical Package for Social Sciences software, version 20 (SPSS Inc., Chicago, IL, USA). Data were presented as mean 6 SD, numbers, and percentages. Analysis of variance, followed by post hoc tests, was used for comparison of parametric data. The Kruskal Wallis test was used to compare nonparametric data while Mann-Whitney was used to compare between the two groups. The chisquare test was used for comparison between percentages and frequencies. A P value of less than 0.05 was considered significant.
Results
There were no significant differences between groups in demographic data regarding age, weight, height, BMI, and duration of surgery (P > 0.05) ( Table 1 ). There was no significant difference among groups regarding postoperative pulse rate and mean blood pressure (P > 0.05) (Figures 1 and 2 ). There was a significant increase in sedation score in group M þ K compared with group M, which started from 0 line until six hours postoperation, with no significant differences in sedation score between group K and group M þ K (P > 0.05) ( Figure  3 ). There was a significant reduction in mean VAS score in group M þ K compared with group K, starting two hours until 24 hours postoperation and in group M compared with group K at 12 and 18 hours postoperation (Figure 4) . The time to first request of rescue analgesia was significantly prolonged in group M þ K (12.00 6 2.29 hours) and group M (11.94 6 1.46 hours) compared with group K (6.42 6 1.43 hours) (P > 0.001) ( Table 2 ). The mean total consumption of PCA morphine in the PACU was significantly decreased in group M þ K (6.00 6 2.10 mg) compared with groups M and K (9.23 6 3.50 mg and 12.67 6 3.49 mg, respectively) in the first 24 hours postoperation (P > 0.04) ( Table 2) . Only five patients (16.6%) in group M þ K requested rescue analgesia, while in groups M and K 14 (46.6%) and 22 (73.3%) patients needed rescue analgesia, respectively (Table 2 ). There was significantly higher sedation (P > 0.01) in groups K and M þ K compared with group M. Apart from sedation, there was no significant difference in the incidence of other side effects between the three studied groups ( Figure 5 ).
Discussion
In this study, adding intrathecal ketamine 0.1 mg/kg to intrathecal morphine 0.3 mg had the advantage of reducing the total postoperative morphine consumption in comparison with using either drug alone. The three study groups had an overall good analgesia with the use of postoperative PCA morphine. Sedation scores were higher in the combination group and in the intrathecal ketamine group than in the morphine group. 
Ketamine is a noncompetitive antagonist of the Nmethyl-D-aspartate (NMDA) receptors. It is used for
premedication, sedation, induction, and maintenance of general anesthesia. Central, regional, and local anesthetic and analgesic properties have been reported for ketamine [17] .
Other possible peripheral mechanisms of action of ketamine include binding to multiple opioid receptors (ORs) [18] , binding to monoamine transporters [19] , binding to muscarinic and nicotinic cholinergic receptors and inhibition of function [20] , binding to D2 and 5-HT2 receptors [21] , inhibition of ion channels (Naþ, Ca2þ, Kþ) [22, 23] , decreased activation and migration of microglia [23] , and finally, inhibition of production of inflammatory mediators [24] .
Despite extensive discourse, there is still controversy in the literature as to the safety and analgesic efficacy of ketamine through the intrathecal route [4] [5] [6] 8, 9] . When intrathecal ketamine was evaluated as a sole anesthetic agent [25, 26] , its psychomimetic disturbances and inadequate analgesia precluded its use for this purpose.
Intrathecal ketamine has been studied extensively in animals. Borgbjerg and Svenssson [6] administered preservative-free ketamine 5 mg intrathecally to rabbits for a period of 14 days and concluded that it has no harmful neurotoxic effects, even after repeated injections. On the contrary, Vranken et al. [8] found that repeated administration of preservative-free S(þ)-ketamine for seven days resulted in histopathologic spinal cord changes. However, they argued that there was no significant difference in neurologic status between the two groups after seven days of intrathecal treatment and that not all animals given intrathecal preservative-free S(þ)-ketamine developed neurologic deterioration despite histologic evidence of neurotoxicity. They also postulated that the spinal cords of rabbits may be more sensitive than those of humans. In our opinion, it is the dose of intrathecal ketamine used and the repetition of exposure to ketamine that might play the major role in the resulting neurotoxic changes as the authors used a dose of 0.7 mg/kg of ketamine given daily for successive seven days.
Data from the above and similar studies led to the concept that multiple factors, like preservatives (chlorobutanol and benzethonium chloride), the use of multiple drugs for a long period, and the use of intrathecal catheters may be responsible, in part, for neurological complications [4] [5] [6] 8] , in addition to the doses and concentrations used. By contrast, Yu et al. [9] reported that ketamine provided potent protective effects against the ischemic reperfusion in spinal cord injuries.
Khezri et al. [27] have reported that using ketamine intrathecally at a concentration of 0.1 mg/kg could be a proper alternative to achieve postoperative analgesia as it resulted in no side effects.
A major mechanism of spinal opioid analgesia is inhibition of transmitter release from C-fiber primary afferent terminals. The presynaptic action of opioids, along with the postsynaptic location of NMDA receptors, is the rationale for the combination of these two drugs. The ketamine acts as the agonist with opiate receptors [28, 29] by producing a synergistic effect to achieve the desired level of postoperative analgesia, with concomitant reduction of side effects. This was the rationale for choosing morphine and ketamine in this study.
Sandler et al. [30] suggested that epidural ketamine may have an additive effect on opioids and local anesthetics. Long after that, this was studied by Arati and colleagues, and they concluded that combining ketamine with morphine epidurally provided a synergistic effect with good analgesia and facilitated early mobilization. Side effects like nausea, vomiting, and sedation were minimal in the group of patients who were administered morphine 0.3 mg/kg with ketamine 0.25 mg/kg [31] .
Combining intrathecal morphine with other drugs might not give similar results. Abdel-Ghaffar et al. [32] studied the combination of 0.5 mg morphine and 5 mg dexmedetomidine, and their results didn't support improved analgesia despite the absence of significant adverse effects. The selection of an intrathecal ketamine dose of 0.1 mg/ kg was based on the fact that several previous studies showed that the use of such dose could prolong the duration of analgesia without additional side effects [33] [34] [35] .
In our study, VAS scores in the three groups were kept within a narrow range. Thus, we can say that the three groups experienced an overall equal analgesic effect, but at the expense of the total amount of rescue PCA morphine.
Our findings support the hypothesis of improved analgesia when giving these two drugs intrathecally in combination. But we think that further work on this specific drug combination is needed with trying different doses of both drugs in different surgical situations and, of course, with larger sample size if possible to reach optimal analgesia with the fewest possible untoward effects.
In conclusion, adding intrathecal ketamine 0.1 mg/kg to morphine 0.3 mg in patients who underwent major abdominal cancer surgery reduced the total postoperative morphine consumption in comparison with either drug alone, with an overall good postoperative analgesia in all groups, with no side effects apart from sedation.
